DEFA14A: Lifeway Foods Urges Shareholders to Reject Dissident Nominees

Lifeway Foods issues a strong letter to shareholders, detailing disqualifying track records and ethical failures of dissident director nominees Edward Smolyansky and George Sent.

Summary

• Lifeway Foods, Inc. (LWAY) has issued a press release to shareholders, urging them to reject the nominations of Edward Smolyansky and George Sent to the Board of Directors.
• The company highlights significant concerns regarding the nominees' backgrounds, including Edward Smolyansky's termination for cause as COO in 2022, a $10.4 million mortgage default, and creation of false social media accounts to post negative statements about Lifeway.
• Ludmila Smolyansky, Edward's mother and an aligned shareholder, faces over $2.3 million in federal and state tax liens.
• Lifeway suggests that the personal financial distress of Edward and Ludmila Smolyansky may be driving their demands for a quick sale of the company at any price, potentially not in the best interest of all shareholders.
• George Sent, a Managing Director of Cascadia Capital, is criticized for aligning with Edward Smolyansky despite previously chairing a special committee that investigated Edward's misconduct.
• Institutional Shareholder Services (ISS) previously recommended against voting for proposals put forth by the dissident group, including Mr. Sent, in July 2025.
• Lifeway emphasizes its strong financial performance, including a 788% total shareholder return over the past five years, ~123% revenue growth since FY2019, and six years of uninterrupted quarterly net sales growth.
• The company reported $57.1 million in net sales for Q3 2025, a 29% volume-led increase, with a 300 basis point gross margin expansion and 19% net income growth.
• Lifeway has undertaken significant board refreshment, adding new independent directors with diverse expertise and entering into a Cooperation Agreement with Danone North America PBC.
• The Board will be made up of a majority of New Independent Board Members by the 2026 Annual Meeting, positioning Lifeway for continued success as an independent company or in a value-creating transaction.

Sentiment

Score: 9

Explanation: The filing presents a highly positive outlook for Lifeway Foods, emphasizing strong financial performance, proactive corporate governance, and a robust defense against dissident nominees whose track records are portrayed as highly problematic. The company's results significantly outperform industry benchmarks, and strategic board refreshment is underway, positioning it for continued success.

Positives

• Achieved 788% total shareholder return over the past five years, significantly outperforming peers and the S&P 500.
• Realized ~123% revenue growth since FY2019.
• Recorded six years of uninterrupted quarterly net sales growth, with Q3 2025 marking a record-breaking quarter.
• Reported $57.1 million in net sales for Q3 2025, representing a 29% volume-led increase.
• Expanded gross margin by 300 basis points and grew net income by 19% in Q3 2025, reflecting disciplined operational execution.
• Successfully implemented a board refreshment process, adding four new independent directors (Rachel Drori, Andee Harris, Susie Hultquist, Kirk Chartier) in October and November 2025.
• Entered into a Cooperation Agreement with Danone North America PBC on September 30, 2025, which facilitated the appointment of new independent directors.
• The Board will achieve a majority of New Independent Board Members by the 2026 Annual Meeting, enhancing independence and expertise.
• The company is well-positioned for continued success, either as an independent entity or through a transaction that delivers compelling shareholder value.

Negatives

• Edward Smolyansky was terminated for cause as Lifeway's COO in 2022.
• Edward Smolyansky defaulted on a $10.4 million mortgage in 2025.
• Edward Smolyansky created multiple false social media accounts to post negative statements about Lifeway, including while serving as a director.
• Ludmila Smolyansky, Edward's mother, is facing over $2.3 million in federal and state tax liens.
• George Sent, a former Lead Independent Director and Chair of a special committee investigating Edward's misconduct, has chosen to align with Edward Smolyansky, raising ethical concerns.
• The dissident nominees' actions are suggested to be driven by personal financial distress and liquidity needs, potentially leading them to push for a quick sale at any price, which may not be in the best interest of all shareholders.
• Neither Edward nor Ludmila Smolyansky has purchased Lifeway common stock in the last five years, instead selling over 2.5 million shares, including 1.1 million shares below $8.00.

Risks

• The dissident nominees' personal financial distress and liquidity needs could lead them to prioritize a quick sale of the company at any price, potentially undermining long-term shareholder value.
• The ongoing proxy contest and potential election of dissident nominees could disrupt current strategic initiatives and operational execution.
• Edward Smolyansky's history of misconduct, including termination for cause, founding a competitor, and posting false statements, poses a risk to corporate governance and company reputation if he were to serve on the Board.
• George Sent's reversal of principle in aligning with Edward Smolyansky, despite his prior role in investigating misconduct, raises concerns about his judgment and ethical standards.
• Forward-looking statements are subject to risks and uncertainties, including price competition, customer/consumer decisions, competitor actions, changes in commodity pricing, government regulation, possible delays in new product introductions, and customer acceptance of products and services.

Future Outlook

Lifeway is positioned for continued success, whether as an independent company or through a transaction that achieves compelling value for shareholders. The Board will be comprised of a majority of New Independent Board Members by the 2026 Annual Meeting, enhancing governance and strategic direction. The company anticipates continued growth, but acknowledges risks related to market competition, consumer preferences, commodity pricing, and regulatory changes.

Management Comments

• "The track record of the Dissident Nominees demonstrates they are unfit to serve on the Company's Board of Directors and lead the Company and pose a clear risk to shareholder value."
• "The Dissident Nominees have disqualifying issues raising ethical concerns."
• "The Dissident's personal financial distress and that of Ludmila Smolyansky, his mother... seem to be fueling their demands for a sale of the Company at any price and could cause the Dissident Nominees to vote in ways that help the Dissident and his mother personally but are not in the best interests of other shareholders."
• "This pattern of contradictory statements, misinformation, and demonstrated financial irresponsibility raises grave concerns about his fitness to serve as a fiduciary, his ability to act in the best interests of all shareholders rather than himself and his mother, and his judgment in overseeing any public company."
• "Lifeway's Board and management have delivered results."
• "Lifeway's Board is committed to refreshing the Board in a thoughtful manner replacing long serving directors and adding new directors whose skills and knowledge increase the Board's independence, breadth of experience and effectiveness."
• "Under the current Board as adjusted in 2026, Lifeway is well positioned for continued success, whether as an independent company or in a transaction that achieves a compelling value for Lifeway shareholders."
• "Replacing any of the Company's current directors with the dissident candidates is not in the best interests of Lifeway or its shareholders. We urge you to reject the Dissident's solicitation on behalf of the Dissident Nominees and the Dissident's proposal and protect the value of your investment."

Industry Context

Lifeway Foods operates as a leading U.S. supplier in the growing market for kefir and fermented probiotic products. The company's strong financial performance, including outperforming peers in the Russell 3000 Food Producers Index and the S&P 500, indicates robust market positioning. The unsolicited acquisition proposal from Danone North America PBC highlights the strategic value of Lifeway within the 'good for you food' consumer product sector, suggesting industry consolidation interest and recognition of Lifeway's brand and market share.

Comparison to Industry Standards

• Lifeway's 788% total shareholder return over the past five years dramatically outperforms peers in the Russell 3000 Food Producers Index and the S&P 500, indicating superior market performance compared to broader industry and market benchmarks.
• The company's consistent revenue growth and gross margin expansion demonstrate strong operational execution relative to industry standards, particularly within the competitive food and beverage sector.
• The unsolicited proposal from Danone North America PBC at $25.00 per share suggests that a major industry player recognizes Lifeway's value, potentially valuing it above its current trading price prior to the offer, and indicating a premium compared to similar companies or projects in the 'good for you food' segment.

Management Changes

Corporate Governance

Legal Proceedings

• Edward Smolyansky is subject to an emergency protection order prohibiting him from communicating with or going near Lifeway's CEO, Julie Smolyansky.
• Ludmila Smolyansky is facing over $2.3 million in federal and state tax liens, including specific liens filed by the IRS and Illinois Department of Revenue in 2022.

Related Party Transactions

• Edward Smolyansky, a former COO and director, is the son of Ludmila Smolyansky, with whom he files Schedule 13Ds and votes. Both are related to CEO Julie Smolyansky.
• Edward Smolyansky founded a direct competitor of Lifeway, indicating a conflict of interest.

Stakeholder Impact

• **Shareholders**: The outcome of the proxy contest will directly impact shareholder value, with the company arguing that rejecting dissident nominees protects investment value. Strong financial performance and board refreshment aim to benefit all shareholders.
• **Employees**: Stability and strategic direction under the current board could provide a more secure environment, while a quick sale pushed by dissidents could lead to uncertainty or job changes.
• **Customers**: Continued focus on product quality and innovation under the current management ensures ongoing supply of kefir and probiotic products.
• **Creditors**: The company's strong financial health and disciplined operational execution provide confidence in its ability to meet financial obligations.
• **Suppliers**: Stable management and growth trajectory suggest continued business relationships and demand for raw materials.

Next Steps

• Shareholders are urged to reject the Dissident's solicitation on behalf of the Dissident Nominees and the Dissident's proposal at the 2025 Annual Meeting.
• Pol Sikar will not be nominated for re-election at the 2025 Annual Meeting.
• Jason Scher will not be nominated for re-election at the 2026 Annual Meeting.
• By the 2026 Annual Meeting, the Board will be made up of a majority of New Independent Board Members.

Key Dates

Recommendation

Lifeway Foods demonstrates exceptional financial performance, significantly outperforming industry peers and the S&P 500 with a 788% TSR over five years and consistent revenue and net income growth. The company is proactively strengthening its corporate governance through thoughtful board refreshment, adding highly qualified independent directors and reducing long-serving members. The detailed critique of the dissident nominees' track records and motivations, coupled with ISS's prior recommendation against them, suggests that the current management and board are better positioned to drive long-term shareholder value. The company's strategic positioning in the growing probiotic market and its ability to attract an unsolicited acquisition proposal from Danone further underscore its intrinsic value. Rejecting the dissident nominees appears to be in the best interest of maximizing shareholder returns.

Keywords

Lifeway Foods, LWAY, Proxy Fight, Shareholder Letter, Board of Directors, Corporate Governance, Dissident Nominees, Edward Smolyansky, George Sent, Kefir, Probiotic Products, Financial Performance, SEC Filing, Danone, Shareholder Value